Baird Financial Group Portfolio holdings
AUM
$57B
This Quarter Return
+1.66%
1 Year Return
+20.87%
3 Year Return
+74.96%
5 Year Return
+130.49%
10 Year Return
+303.64%
AUM
$52.3B
AUM Growth
+$52.3B
(+1.5%)
Cap. Flow
+$998M
Cap. Flow
% of AUM
1.91%
Top 10 Holdings %
Top 10 Hldgs %
24.63%
Holding
1,840
New
93
Increased
889
Reduced
671
Closed
94
Top Buys
| 1 |
Meta Platforms (Facebook)
META
|
$155M |
| 2 |
iShares Core S&P Small-Cap ETF
IJR
|
$105M |
| 3 |
Schwab US Dividend Equity ETF
SCHD
|
$78.3M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
$55.6M |
| 5 |
Datadog
DDOG
|
$55M |
Top Sells
| 1 |
Cisco
CSCO
|
$122M |
| 2 |
iShares Russell 2000 ETF
IWM
|
$67.9M |
| 3 |
Shift4
FOUR
|
$44M |
| 4 |
ANSS
Ansys
ANSS
|
$41.9M |
| 5 |
AppFolio
APPF
|
$38M |
Sector Composition
| 1 | Technology | 19.2% |
| 2 | Financials | 13.83% |
| 3 | Industrials | 10.43% |
| 4 | Consumer Discretionary | 8.48% |
| 5 | Healthcare | 6.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Leap Therapeutics
LPTX
$12.2M
| $83.1K | ﹤0.01% |
28,900
| – | – |
|
1727
Lucid Motors
LCID
$52B
| $79.8K | ﹤0.01% |
26,430
-2,900
| -10% | -$8.76K |
|
1728
Terns Pharmaceuticals
TERN
$635M
| $77.7K | ﹤0.01% |
14,020
-189
| -1% | -$1.05K |
|
1729
fuboTV
FUBO
$1.25B
| $76.7K | ﹤0.01% |
60,891
-13,000
| -18% | -$16.4K |
|
1730
Invesco Municipal Income Opportunities Trust
OIA
$272M
| $74.1K | ﹤0.01% |
12,555
| – | – |
|
1731
Plug Power
PLUG
$1.73B
| $65.3K | ﹤0.01% |
30,667
-362,901
| -92% | -$773K |
|
1732
Information Services Group
III
$250M
| $60.3K | ﹤0.01% |
18,057
-136
| -0.7% | -$454 |
|
1733
Navitas Semiconductor
NVTS
$1.22B
| $56.7K | ﹤0.01% |
15,882
-28,292
| -64% | -$101K |
|
1734
Gevo
GEVO
$392M
| $52.3K | ﹤0.01% |
25,000
-10,000
| -29% | -$20.9K |
|
1735
Globalstar
GSAT
$3.82B
| $51.8K | ﹤0.01% |
25,000
| – | – |
|
1736
Invesco Senior Income Trust
VVR
$556M
| $51.4K | ﹤0.01% |
13,000
-1
| -0% | -$4 |
|
1737
OPAL Fuels
OPAL
$65.8M
| $44.9K | ﹤0.01% |
13,249
| – | – |
|
1738
Geron
GERN
$887M
| $40.7K | ﹤0.01% |
11,500
| – | – |
|
1739
Editas Medicine
EDIT
$225M
| $39.1K | ﹤0.01% |
30,751
-5,234
| -15% | -$6.65K |
|
|
NGD
1740
New Gold Inc
NGD
$4.84B
| $34.8K | ﹤0.01% |
14,050
+1,375
| +11% | +$3.41K |
|
1741
Akebia Therapeutics
AKBA
$811M
| $33K | ﹤0.01% |
17,393
| – | – |
|
1742
Karyopharm Therapeutics
KPTI
$60.4M
| $30.3K | ﹤0.01% |
44,800
+7,000
| +19% | +$4.73K |
|
|
CLLS
1743
Cellectis
CLLS
$261M
| $27.2K | ﹤0.01% |
15,090
| – | – |
|
1744
B2Gold
BTG
$5.45B
| $25.6K | ﹤0.01% |
10,500
| – | – |
|
|
NAK
1745
Northern Dynasty Minerals
NAK
$478M
| $17.8K | ﹤0.01% |
30,600
| – | – |
|
1746
Wallbox
WBX
$66M
| $8.13K | ﹤0.01% |
16,245
-2,691
| -14% | -$1.35K |
|
1747
Axcelis
ACLS
$2.44B
| – | – |
-16,471
| Closed | -$1.73M |
|
1748
Affirm
AFRM
$27.5B
| – | – |
-11,678
| Closed | -$477K |
|
1749
Algonquin Power & Utilities
AQN
$4.32B
| – | – |
-19,154
| Closed | -$104K |
|
1750
Axsome Therapeutics
AXSM
$6.03B
| – | – |
-10,118
| Closed | -$909K |
|